yanyanyan
Lv1
70 积分
2023-11-21 加入
-
Phase Ib study of anlotinib in combination with anti‐PD‐L1 antibody (TQB2450) in patients with advanced acral melanoma
9天前
已完结
-
Timing of surgery and bevacizumab therapy in neurosurgical patients with recurrent high grade glioma
30天前
已完结
-
Systemic lupus erythematosus reactivation after chemoimmunotherapy in preexisting autoimmune disease
1个月前
已完结
-
A Phase III, Randomized, Multi-Center, Open-Label, Fixed Dose, Neulasta Active-Controlled Clinical Trial of F-627, a Novel G-CSF, in Women with Breast Cancer Receiving Myelotoxic Chemotherapy
1个月前
已关闭
-
Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial
1个月前
已完结
-
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
1个月前
已完结
-
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
1个月前
已完结
-
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
-
Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (RATIONALE-312): a Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial
1个月前
已完结
-
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)]
4个月前
已完结